isomethyleugenol has been researched along with sildenafil citrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyland, R; Jones, BC; Roe, EG; Smith, DA | 1 |
| Beasley, A; Blount, MA; Corbin, JD; Francis, SH | 1 |
2 other study(ies) available for isomethyleugenol and sildenafil citrate
| Article | Year |
|---|---|
Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Methylation; Microsomes, Liver; Mixed Function Oxygenases; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyrimidinones; Recombinant Proteins; Sildenafil Citrate; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Sulfones | 2001 |
Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5).
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Humans; Imidazoles; Male; Methylation; Models, Molecular; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Structure-Activity Relationship; Sulfones; Triazines; Vardenafil Dihydrochloride | 2004 |